All In Biotech

Drug Trial Radar · NCT06993610

Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense

A Phase 2, Multi-Center Study Consisting of a Randomized, Placebo-Controlled Period, Followed by an Open-Label Extension Period to Assess the Efficacy, Safety, and Tolerability of Tibulizumab in Adults With Hidradenitis Suppurativa

Last checked: Nov 20, 2026Latest source record: Oct 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 247 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

247

Actual

Start

May 16, 2025

Primary completion

Sep 18, 2026

Study completion Apr 2027

Sponsor

Lead sponsor
Zura Bio IncIndustry
Sponsor type
Industry
First posted
May 29, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study is a Phase 2, multi-center, randomized, double-blind, placebo-controlled study to evaluate the effects of tibulizumab over 16 weeks (Period 1) in adults with hidradenitis suppurativa, followed by a 16-week open-label extension period in which all participants will receive tibulizumab (Period 2)

Conditions

  • Hidradenitis Suppurativa (HS)

Interventions

  • Tibulizumab Dose ABiological

    Anti BAFF/IL-17 antibody. ZB-106

  • Tibulizumab Dose BBiological

    Anti BAFF/IL-17 antibody. ZB-106

  • PlaceboOther

    ZB-106 Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. [Period 1] Percent change from baseline in abscess and inflammatory nodule (AN) count at 16 weeksTime frame: Week 16

Locations

61 sites in 6 countries. Site status is shown where the registry gives one.

  • Medical Dermatology Specialists (Phoenix)

    Phoenix, Arizona

  • First OC Dermatology Research, Inc.

    Irvine, California

  • Wallace Medical Group, Inc.

    Los Angeles, California

  • Northridge Clinical Trials

    Northridge, California

  • NorCal Clinical Research

    Rocklin, California

  • Florida Academic Dermatology Center

    Coral Gables, Florida

  • Skin Care Research, LLC

    Hollywood, Florida

  • Georgia Skin & Cancer Clinic

    Savannah, Georgia

  • Indiana University School of Medicine

    Indianapolis, Indiana

  • The Indiana Clinical Trials Center

    Plainfield, Indiana

  • Equity Medical LLC (Kentucky)

    Bowling Green, Kentucky

  • DS Research of Kentucky, LLC

    Louisville, Kentucky

  • DelRicht LLC

    Baton Rouge, Louisiana

  • Clinical Trials Management, LLC

    Metairie, Louisiana

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts

  • MediSearch Clinical Trials

    Saint Joseph, Missouri

  • Skin Cancer and Dermatology Institute

    Reno, Nevada

  • Equity Medical

    New York, New York

  • OptiSkin Medical

    New York, New York

  • Red River Research Partners

    Fargo, North Dakota

  • Optima Research

    Boardman, Ohio

  • ClinOhio Research Services

    Columbus, Ohio

  • Apex Clinical Research Center

    Mayfield Heights, Ohio

  • Best Skin Research LLC

    Camp Hill, Pennsylvania

  • Palmetto Clinical Trial Services

    Anderson, South Carolina

  • DelRicht Research

    Mt. Pleasant, South Carolina

  • International Clinical Research - Tennessee LLC

    Murfreesboro, Tennessee

  • Dermatology Treatment and Research Center

    Dallas, Texas

  • BRCR Global Texas

    Katy, Texas

  • DelRicht Research

    Prosper, Texas

  • Progressive Clinical Research

    San Antonio, Texas

  • Frontier Dermatology

    Mill Creek, Washington

  • University of Washington Medical Center

    Seattle, Washington

  • Dermatology Specialists of Spokane

    Spokane, Washington

  • Ryan Clinical Research Inc.

    Newmarket, Ontario, Canada

  • North York Research Inc

    North York, Ontario, Canada

  • York Dermatology Clinic & Research Centre

    Richmond Hill, Ontario, Canada

  • Centre de recherche Saint-Louis

    Québec, Quebec, Canada

  • Saskatoon Dermatology Centre

    Saskatoon, Saskatchewan, Canada

  • Fachklinik Bad Bentheim

    Bad Bentheim, Germany

Showing 40 of 61 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.